CA9 Antikörper (C-Term)

Produktnummer ABIN540761

Produktdetails anti-CA9 Antikörper

Target: CA9 (Carbonic Anhydrase IX (CA9))

Bindungsspezifität: C-Term

Reaktivität: Human, Ratte, Hund

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CA9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro))

Verwendungszweck: Rabbit polyclonal antibody raised against synthetic peptide of CA9.

Spezifität: This antibody is specific to human CA IX.

Kreuzreaktivität: Hund, Human, Ratte

Immunogen: A synthetic peptide corresponding to C-terminus of human CA9.

Anwendungsinformationen

Applikationshinweise: Immunofluorescence (1:1000)
Immunohistochemistry (Frozen sections) (1:1000)
Western Blot (1:2000)
The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In PBS (0.025 % sodium azide)

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-CA9 Antikörper (ABIN540761)

Sathornsumetee, Cao, Marcello, Herndon, McLendon, Desjardins, Friedman, Dewhirst, Vredenburgh, Rich: "Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, Issue 2, pp. 271-8, (2008) (PubMed).

Sakata, Someya, Nagakura, Nakata, Oouchi, Takagi, Hareyama: "Brachytherapy for oral tongue cancer: an analysis of treatment results with various biological markers." in: Japanese journal of clinical oncology, Vol. 38, Issue 6, pp. 402-7, (2008) (PubMed).

Yoo, Baia, Smith, McDermott, Bollen, Vandenberg, Lamborn, Lal: "Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 13, Issue 1, pp. 68-75, (2007) (PubMed).

Westbury, Pearson, Nerurkar, Reis-Filho, Steele, Peckitt, Sharp, Yarnold: "Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride." in: The British journal of radiology, Vol. 80, Issue 959, pp. 934-8, (2007) (PubMed).

Kaidi, Moorghen, Williams, Paraskeva: "Is the downregulation of EphB2 receptor expression during colorectal tumorigenesis due to hypoxia?" in: Gut, Vol. 56, Issue 11, pp. 1637-8, (2007) (PubMed).

Details zu CA9

Target: CA9 (Carbonic Anhydrase IX (CA9))

Andere Bezeichnung: Carbonic anhydrase 9 (CA9 Produkte)

Synonyme: CA9 antikoerper, CAIX antikoerper, Ca9 antikoerper, MN/CA9 antikoerper, MN antikoerper, carbonic anhydrase 9 antikoerper, CA9 antikoerper, CAH9 antikoerper, Car9 antikoerper

Gen-ID: 768